Philip Morris International (PMI) is one of the world's largest consumer goods companies, selling cigarettes and smoke-free nicotine products in approximately 170 markets. PMI's cigarette portfolio is anchored by Marlboro, the world's best-selling international cigarette brand, which accounts for roughly 43% of PMI's cigarette shipment volume. Cigarettes remain a key profit contributor — PMI raises prices annually and extracts consistent gross profit growth from a slowly declining volume base, using combustible cash flows to fund its smoke-free expansion. PMI's primary growth engine is its smoke-free products (SFPs), which now account for roughly 41.5% of total net revenues. SFPs span three categories: IQOS (heated tobacco), ZYN (nicotine pouches), and VEEV (e-vapor). IQOS follows a razor-and-blades model — devices are sold at or near cost, with recurring revenue driven by proprietary tobacco sticks (HEETS, TEREA). ZYN is a tobacco-free oral nicotine pouch with no device component, carrying higher gross margins than even IQOS. VEEV is a closed-pod vaping system growing rapidly but still smaller than IQOS and ZYN. PMI sells primarily through distributors globally, with e-commerce and brand retail used selectively for smoke-free products. PMI's core strategy is converting adult smokers from cigarettes to smoke-free products while maximizing value from the combustible business. The U.S. is PMI's highest-priority incremental growth market, driven by ZYN — the leading U.S. nicotine pouch brand — alongside anticipated expansion of IQOS pending FDA authorization.